Exact Mass: 419.06411380000003
Exact Mass Matches: 419.06411380000003
Found 122 metabolites which its exact mass value is equals to given mass value 419.06411380000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Prosulfuron
C15H16F3N5O4S (419.08750520000007)
CONFIDENCE standard compound; INTERNAL_ID 2617
ZOPOLRESTAT
C471 - Enzyme Inhibitor > C72880 - Aldose Reductase Inhibitor D007004 - Hypoglycemic Agents D004791 - Enzyme Inhibitors
S-(2,2-Dichloro-1-hydroxy)ethyl glutathione
C12H19Cl2N3O7S (419.03207240000006)
This compound belongs to the family of Peptides. These are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.
Nitrobenzylthioinosine
C17H17N5O6S (419.08995020000003)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D000345 - Affinity Labels Nitrobenzylthioinosine is an ENT1 transporter inhibitor that binds to ENT1 transporter with high affinity. Nitrobenzylthioinosine is a photoaffinity probe for adenosine uptake sites in brain. Nitrobenzylthioinosine can cross the blood-brain barrier[1][2][3]. Nitrobenzylthioinosine is an ENT1 transporter inhibitor that binds to ENT1 transporter with high affinity. Nitrobenzylthioinosine is a photoaffinity probe for adenosine uptake sites in brain. Nitrobenzylthioinosine can cross the blood-brain barrier[1][2][3].
[3-[1-Formyl-2-(2-furanyl)ethenyl]]-2-(2-furanyl)-5-(2-furanylmethylene)-4,5-dihydro-a-methyl-4-oxo-1H-pyrrole-1-acetic acid, 9CI
[3-[1-Formyl-2-(2-furanyl)ethenyl]]-2-(2-furanyl)-5-(2-furanylmethylene)-4,5-dihydro-a-methyl-4-oxo-1H-pyrrole-1-acetic acid, 9CI is a maillard product from reaction of L-alanine and 2-Furancarboxaldehyde
Cyanidin 3-arabinoside
C20H19O10+ (419.09781740000005)
Isolated from numerous plant subspecies including red pears and apples. Cyanidin 3-arabinoside is found in many foods, some of which are common grape, american cranberry, blackcurrant, and lingonberry. Cyanidin 3-arabinoside is found in american cranberry. Cyanidin 3-arabinoside is isolated from numerous plant species including red pears and apples.
Cyanidin 3-xyloside
C20H19O10+ (419.09781740000005)
Isolated from apples. Cyanidin 3-xyloside is found in many foods, some of which are pomes, summer grape, apple, and black chokeberry. Cyanidin 3-xyloside is found in american cranberry. Cyanidin 3-xyloside is isolated from apples.
Cyanidin 7-arabinoside
C20H19O10+ (419.09781740000005)
Isolated from the apple tree Malus species Cyanidin 7-arabinoside is found in malus (crab apple) and pomes. Cyanidin 7-arabinoside is found in pomes. Cyanidin 7-arabinoside is isolated from the apple tree Malus sp.
2-Chloro-N-[1-[(2R)-2,3-dihydroxypropyl]-2-oxo-3,4-dihydroquinolin-3-yl]-6H-thieno[2,3-b]pyrrole-5-carboxamide
C19H18ClN3O4S (419.07064980000007)
Methyl 5-(benzylcarbamoylamino)-3-(2,6-dichlorophenyl)-1,2-oxazole-4-carboxylate
C19H15Cl2N3O4 (419.04395700000003)
4-Nitrobenzylthioinosine
C17H17N5O6S (419.08995020000003)
Nitrobenzyl-6-thioinosine
C17H17N5O6S (419.08995020000003)
9-[(2R,3R,4S,5S)-3,4-Dihydroxy-5-[(4-nitrophenyl)methylsulfanylmethyl]oxolan-2-yl]-1H-purin-6-one
C17H17N5O6S (419.08995020000003)
Cyanidin 3-O-alpha-L-arabinoside
C20H19O10 (419.09781740000005)
Cyanidin 3-o-alpha-l-arabinoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Cyanidin 3-o-alpha-l-arabinoside can be found in cocoa bean and highbush blueberry, which makes cyanidin 3-o-alpha-l-arabinoside a potential biomarker for the consumption of these food products.
4-Methylthio-3-butenyl glucosinolate
C12H21NO9S3 (419.03784160000004)
Cyanidin 3-o-alpha-L-arabinopyranoside
C20H19O10 (419.09781740000005)
Rosacyanin B
Cyanidin 3-arabinoside
C20H19O10 (419.09781740000005)
bromperidol
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AD - Butyrophenone derivatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Bromperidol (R-11333) possesses antipsychotic activity, with a high affinity for central dopamine receptors D2. Bromperidol can kill Mycobacteria in a synergistic manner with Spectinomycin[1][2].
2-[[3,4-Dihydro-1-oxo-3-methyl-4,8-dihydroxy-5-chloro-1H-2-benzopyran-7-yl]carbonylamino]-3-phenylpropanoic acid
Cyanidin-3-O-alpha-arabinopyranoside
[C20H19O10]+ (419.09781740000005)
Acquisition and generation of the data is financially supported in part by CREST/JST.
Cyanidin-3-O-alpha-arabinoside
[C20H19O10]+ (419.09781740000005)
Annotation level-1
4-Hydroxy-N-(2-diethylaminoethyl)benzamide
Cyanidin 3-xyloside
C20H19O10 (419.09781740000005)
Cyanidin 7-arabinoside
C20H19O10 (419.09781740000005)
Methantheline Bromide
C21H26BrNO3 (419.10959460000004)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists
Mepenzolate bromide
C21H26BrNO3 (419.10959460000004)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent
2-[(3-iodo-6-nitroindazol-1-yl)methoxy]ethyl-trimethylsilane
1-{2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-ethyl-[1,3]dioxolan-2-ylmethyl}-1H-[1,2,4]triazole
C20H19Cl2N3O3 (419.08034040000007)
3-(6-CHLORO-5-FLUOROPYRIMIDIN-4-YL)-2,(2,4-DIFLUORO PHENYL) - 1-(1H-1,2,4-TRIAZOLE-1-YL)BUTAN-2-OL HYDROCHLORIDE
benzyl (S)-2-(N-t-butoxycarbonylamino)-4-iodobutanoate
C16H22INO4 (419.05935220000003)
Ethanaminium,2-[[2-cyclopentyl-2-hydroxy-2-(2-thienyl)acetyl]oxy]-N,N-diethyl-N-methyl-,bromide (1:1)
C18H30BrNO3S (419.11296500000003)
1-(2,6-DICHLOROBENZYL)THIOETHYL-2-METHYL 5-PHENYLPYRROLE-3-CARBOXYLIC ACID
C21H19Cl2NO2S (419.05134940000005)
1-Butyl-3-Methylimidazolium Bis(Trifluoromesulfonyl)imide
Ethyl 6-bromo-5-hydroxy-1-methyl-2-(phenylsulfanylmethyl)indole-3-carboxylate
Phosphonium,(4-nitrophenyl)triphenyl-,chloride
C24H19ClNO2P (419.0841874000001)
0,11-DIMETHOXY-6-METHYL-5,6-DIHYDRO-4H-DIBENZO[DE,G]QUINOLINE
Clopidogrel bisulfate
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors Clopidogrel hydrogen sulfate is an antiplatelet agent to prevent blood clots. Clopidogrel hydrogen sulfate inhibits CYP2B6 and CYP2C19 with IC50s of 18.2 nM and 524 nM, respectively[1]. Clopidogrel hydrogen sulfate is a potent antithrombotic agent that inhibits ADP-induced platelet aggregation[2]．Clopidogrel hydrogen sulfate also is an orally active P2Y(12) inhibitor[5].
1H-Benzimidazole,5,6-dimethyl-1-[[4-(1-pyrrolidinylsulfonyl)phenyl]sulfonyl]-(9CI)
C19H21N3O4S2 (419.09734260000005)
8-azido-5-ethyl-6-phenylphenanthridin-5-ium-3-amine,bromide
Troriluzole
C15H16F3N5O4S (419.08750520000007)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C26170 - Protective Agent > C1509 - Neuroprotective Agent
Methyl 2-(perfluorobenzamido)-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylate
(4-{[Allyl(methyl)amino]methyl}-1,1-biphenyl-4-YL)(4-bromophenyl)methanone
Isoquinoline-5-sulfonic acid (2-(2-(4-chlorobenzyloxy)ethylamino)ethyl)amide
C20H22ClN3O3S (419.10703320000005)
3-({4-[(5-Chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide
C17H14ClN5O4S (419.04549940000004)
3-[2-Bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile
9-[2-benzyl-3,4-dihydroxy-5-(hydroxymethyl)-3-nitrooxolan-2-yl]-3H-purine-6-thione
C17H17N5O6S (419.08995020000003)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D000345 - Affinity Labels
Plavix
D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
4-Fluorobenzoic acid 4-[[5-(5-quinolinyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester
N-[4-[5-(4-chlorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-2-(4-methoxyphenyl)acetamide
C23H18ClN3O3 (419.10366280000005)
[2-methoxy-5-[(E)-[(3-nitrobenzoyl)hydrazinylidene]methyl]phenyl] benzoate
N-[3-chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide
C23H18ClN3O3 (419.10366280000005)
2-[[2-[[5-(4-Ethylanilino)-1,3,4-thiadiazol-2-yl]thio]-1-oxoethyl]amino]-3-thiophenecarboxamide
N-[4-(diethylsulfamoyl)phenyl]-2-(2-oxo-1,3-benzothiazol-3-yl)acetamide
C19H21N3O4S2 (419.09734260000005)
7-[(3-Bromophenyl)methyl]-1,3-dimethyl-8-(2-methylpropylamino)purine-2,6-dione
N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-2-(2-pyrimidinylthio)acetamide
2-[(6-amino-3,5-dicyano-4-thiophen-2-yl-2-pyridinyl)thio]-N-(2-phenylethyl)acetamide
methyl 3-{[1-(4-methoxyphenyl)-2,4,6-trioxotetrahydro-5(2H)-pyrimidinylidene]methyl}-1H-indole-2-carboxylate
[4-(7-Chloro-4-quinolinyl)-1-piperazinyl]-(3,4-dichlorophenyl)methanone
[4-[[5-(2,4-Dichlorophenyl)-3-isoxazolyl]-oxomethyl]-1-piperazinyl]-(2-furanyl)methanone
C19H15Cl2N3O4 (419.04395700000003)
N-(6-amino-1-benzyl-2,4-dioxopyrimidin-5-yl)-2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-N-methylacetamide
5-Bromo-2-[[2-(4-tert-butylphenoxy)-1-oxoethyl]amino]benzoic acid methyl ester
C20H22BrNO4 (419.07321120000006)
N-{2-[(S)-(4,6-dimethoxypyrimidin-2-yl)(hydroxy)methyl]-6-(methoxymethyl)phenyl}-1,1-difluoromethanesulfonamide
C16H19F2N3O6S (419.09625780000005)
N-{2-[(R)-(4,6-dimethoxypyrimidin-2-yl)(hydroxy)methyl]-6-(methoxymethyl)phenyl}-1,1-difluoromethanesulfonamide
C16H19F2N3O6S (419.09625780000005)
6-Fluoro-3-pyridinecarboxylic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester
1-S-[(1Z)-5-(methylsulfinyl)-N-(sulfooxy)pent-4-enimidoyl]-1-thio-beta-D-glucopyranose
C12H21NO9S3 (419.03784160000004)
2-[(1S,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid
C20H21NO7S (419.10386760000006)
2-[(1R,3R,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid
C20H21NO7S (419.10386760000006)
2-[(1R,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid
C20H21NO7S (419.10386760000006)
2-[(1S,3R,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid
C20H21NO7S (419.10386760000006)
[(1R)-7-methoxy-1-thiophen-2-ylsulfonyl-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C19H21N3O4S2 (419.09734260000005)
[(1S)-7-methoxy-1-thiophen-2-ylsulfonyl-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C19H21N3O4S2 (419.09734260000005)
(2S)-1-[(2E)-2-[(2S)-2,6-dicarboxy-2,3-dihydro-1H-pyridin-4-ylidene]ethylidene]-7-oxo-2,3-dihydropyrano[3,4-b]pyrrol-1-ium-2,5-dicarboxylic acid
(2S,5S)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxyoxane-3,4,5-triol
C20H19O10+ (419.09781740000005)
S-(2,2-Dichloro-1-hydroxy)ethyl glutathione
C12H19Cl2N3O7S (419.03207240000006)
[3-[1-Formyl-2-(2-furanyl)ethenyl]]-2-(2-furanyl)-5-(2-furanylmethylene)-4,5-dihydro-a-methyl-4-oxo-1H-pyrrole-1-acetic acid, 9CI
Glucoraphenin
C12H21NO9S3 (419.03784160000004)
A glucosinolic acid that consists of 1-thio-beta-D-glucopyranose attached to a 1-(methylsulfinyl)-5-[(sulfooxy)imino]pent-1-en-5-yl group at the anomeric sulfur.
(Rac)-PT2399
C17H10F5NO4S (419.0250680000001)
(Rac)-PT2399 (Compound 10e), the racemate of PT2399, acts as a potent and specific hypoxia-inducible factor 2a (HIF-2α) inhibitor with an IC50 of 0.01 μM[1].
Kobe2602
C14H9F4N5O4S (419.03113620000005)
Kobe2602 is a Ras-Raf interaction inhibitor. Kobe2602 inhibits the binding of H-Ras·GTP to c-Raf-1 RBD with a Ki of 149 μM. Kobe2602 has antitumor activity[1].
PT2399
C17H10F5NO4S (419.0250680000001)
PT2399 is a potent and selective HIF-2α antagonist, which directly binds to HIF-2α PAS B domain with an IC50 of 6 nM. PT2399 displays potent antitumor activity in vivo[1][2][3].
WAY208466 (dihydrochloride)
WAY 208466 dihydrochloride is a potent and selective 5-HT6 receptor agonist (EC50=7.3 nM for the human 5-HT6 receptor). WAY-208466 dihydrochloride elevates cortical GABA levels in rat frontal cortex[1]. WAY 208466 dihydrochloride exhibits antidepressant and anxiolytic-like effects[2].
21-hydroxy-9-methoxy-17-(methylamino)-6-oxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁵,²⁰]henicosa-1(13),3,8,10,14,17,20-heptaene-2,7,12,16,19-pentone
C22H13NO8 (419.06411380000003)
{[5-(methylsulfanyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino}oxysulfonic acid
C12H21NO9S3 (419.03784160000004)
[(z)-(5-methoxy-5-oxo-1-{[(2r,3r,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pentylidene)amino]oxysulfonic acid
3-{[(2s,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-1λ⁴-chromen-1-ylium
[C20H19O10]+ (419.09781740000005)
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2r,3r,4r,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1λ⁴-chromen-1-ylium
[C20H19O10]+ (419.09781740000005)
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2s,3s,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-1λ⁴-chromen-1-ylium
[C20H19O10]+ (419.09781740000005)
7-(3,4-dihydroxyphenyl)-3,13,14-trihydroxy-10-oxo-6,9,19λ⁴-trioxapentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-1(19),2,4,7,11,13,15,17-octaen-19-ylium
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[(1z)-5-methanesulfinyl-1-(sulfoimino)pent-4-en-1-yl]sulfanyl}oxane-3,4,5-triol
C12H21NO9S3 (419.03784160000004)
[(z)-[(4e)-5-(methylsulfanyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid
C12H21NO9S3 (419.03784160000004)